1. Switzerland Stocks

  2. •

    Health technology

  3. •

    Pharmaceuticals: major
Basilea Pharmaceutica AG

Basilea Pharmaceutica AG

72.60
EUR
+0.20
(+0.28%)
Feb 16Next Earn

Important Dates

Basilea Pharmaceutica AG's next confirmed earnings release is scheduled for February 16, 2027.

Earnings Date2/16/2027

Share Statistics

As of June 30, 2026, Basilea Pharmaceutica AG has 12.38M shares outstanding.

Shares Outstanding12.38M

Financial Position

As of June 30, 2026, Basilea Pharmaceutica AG maintains a current ratio of 6.60, meaning it holds 6.6x the short-term assets needed to cover near-term liabilities.

Current Ratio6.60
Quick Ratio4.17
Debt / Equity51.40

Financial Efficiency

These figures cover the twelve months ended June 30, 2026.

Employee Count189.00

Balance Sheet

EUR

As of June 30, 2026, Basilea Pharmaceutica AG holds 187.51M in cash and equivalents against 90.41M in total debt, resulting in a net debt position of -110.96M. Total book value stands at 175.91M, with working capital of 251.69M providing operational flexibility.

Cash & Cash Equivalents187.51M
Total Debt90.41M
Net Debt-110.96M
Equity (Book Value)175.91M
Book Value Per Share14.21
Working Capital251.69M

Stock Splits

Basilea Pharmaceutica AG's most recent stock split took place on March 13, 2007.

Last Split Date3/13/2007